CVE:GSDDevonian Health Group Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Devonian Health Group Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$0.18 0.00 (0.00 %) (As of 07/6/2020 03:28 PM ET) Add Compare Share Today's RangeC$0.19Now: C$0.19▼C$0.1950-Day RangeC$0.12MA: C$0.15▼C$0.2052-Week RangeC$0.09Now: C$0.19▼C$0.44Volume2,500 shsAverage Volume21,566 shsMarket CapitalizationC$15.18 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlinesSocial Media Devonian Health Group Inc., a pharmaceutical company, engages in the development of botanical drugs. Its lead product candidate is Thykamine, which is in Phase II clinical trials for the treatment of ulcerative colitis and atopic dermatitis. It also develops value-added products for dermo-cosmetics. The company was incorporated in 2013 and is headquartered in Québec, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Devonian Health Group. Previous Next 2.4 Community Rank Outperform VotesDevonian Health Group has received 25 “outperform” votes. (Add your “outperform” vote.)Underperform VotesDevonian Health Group has received 27 “underperform” votes. (Add your “underperform” vote.)Community SentimentDevonian Health Group has received 51.92% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Devonian Health Group and other stocks. Vote “Outperform” if you believe GSD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GSD will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldDevonian Health Group does not currently pay a dividend.Dividend GrowthDevonian Health Group does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Devonian Health Group insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Devonian Health Group is -3.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Devonian Health Group is -3.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDevonian Health Group has a P/B Ratio of 1.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.48 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:GSD Previous Symbol CUSIPN/A CIKN/A Webwww.groupedevonian.com Phone450-937-6696Debt Debt-to-Equity Ratio58.71 Current Ratio0.48 Quick Ratio0.40Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$2.43 million Price / Sales6.24 Cash FlowC$0.01 per share Price / Cash Flow14.38 Book ValueC$0.12 per share Price / Book1.52Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares82,079,000Market CapC$15.18 million Next Earnings DateN/A OptionableNot Optionable TSXV:GSD Rates by TradingView Receive GSD News and Ratings via Email Sign-up to receive the latest news and ratings for GSD and its competitors with MarketBeat's FREE daily newsletter. Devonian Health Group (CVE:GSD) Frequently Asked Questions How has Devonian Health Group's stock been impacted by COVID-19 (Coronavirus)? Devonian Health Group's stock was trading at C$0.22 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, GSD shares have decreased by 15.9% and is now trading at C$0.19. View which stocks have been most impacted by Coronavirus. Has Devonian Health Group been receiving favorable news coverage? Media headlines about GSD stock have trended negative on Monday, InfoTrie reports. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Devonian Health Group earned a news sentiment score of -2.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Devonian Health Group. Who are some of Devonian Health Group's key competitors? Some companies that are related to Devonian Health Group include Verona Pharma (VRP), Navidea Biopharmaceuticals (NAVB), Mereo BioPharma Group (MPH), Aerpio Pharmaceuticals (ARPO), Medlab Clinical (MDC), Equillium (EQ), Protalix Biotherapeutics (PLX), Memphasys (MEM), OptiBiotix Health (OPTI), ReNeuron Group (RENE), Zelda Therapeutics (ZLD), OKYO Pharma (OKYO), AmpliPhi Biosciences (ARMP), Botanix Pharmaceuticals (BOT) and Race Oncology (RAC). View all competitors. Who are Devonian Health Group's key executives? Devonian Health Group's management team includes the following people: Dr. Andre P. Boulet, Chairman, Pres, CEO & Sec. (Age 60)Ms. Colette Laurin, CFO & Corp. ControllerMr. Tarique Sayed, Sec. & Director What is Devonian Health Group's stock symbol? Devonian Health Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "GSD." How do I buy shares of Devonian Health Group? Shares of GSD and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Devonian Health Group's stock price today? One share of GSD stock can currently be purchased for approximately C$0.19. How big of a company is Devonian Health Group? Devonian Health Group has a market capitalization of C$15.18 million and generates C$2.43 million in revenue each year. What is Devonian Health Group's official website? The official website for Devonian Health Group is www.groupedevonian.com. How can I contact Devonian Health Group? The company can be reached via phone at 450-937-6696. This page was last updated on 7/6/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
